Entero Therapeutics, Inc. (ENTO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.97M | -855.69K | -54.88K | -818.63K | -171.52K | -1.85M | -3.45M | -3.75M | -3.44M | -3.33M | -2.76M | -2.85M |
| Operating CF Margin % | -10961.42% | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -2216.74% | 53.71% | 98.41% | 78.15% | 95.01% | 44.51% | -24.95% | -31.68% | -61402.15% | 21.69% | 39.77% | 64.03% |
| Net Income | -3.14M | -1.15M | -998.27K | -1.26M | -12.24M | -2.58M | -8.81M | 5.57M | -4.1M | -3.43M | -4.19M | -4.07M |
| Depreciation & Amortization | 574.71K | 0 | 0 | 0 | 0 | 1.34K | 35.32K | 12.29K | 7.32K | 7.32K | 7.32K | 7.32K |
| Stock-Based Compensation | 733.95K | 0 | 0 | 0 | 44.66K | 183.65K | 131.89K | 271.36K | 126.12K | 263.33K | 292.7K | 358.32K |
| Deferred Taxes | -418.63K | 0 | 0 | 0 | 0 | 0 | 4.26M | -14.86M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.72M | 0 | 339.2K | 126.75K | 10.62M | 17.33K | 786.53K | 4.81M | 33.59K | 92.09K | 15.81K | 15.53K |
| Working Capital Changes | 0 | 297.12K | 604.19K | 314.23K | 1.4M | 530.17K | 147.86K | 451.15K | 494.53K | -259.8K | 1.11M | 843.91K |
| Change in Receivables | 7.29K | 0 | 109.32K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 73 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -51.46K | 176.46K | 448.52K | -109.32K | 744.3K | 155.95K | 218.56K | 526.03K | -25.01K | -1.01M | 1.12M | -250.28K |
| Cash from Investing | -12.95K | 336.43K | 0 | 0 | 0 | 0 | 0 | 88.17K | -500 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -500K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | -8.72M | 336.43K | 0 | 0 | 0 | 0 | 0 | 88.17K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 8.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -500 | 0 | 0 | 0 |
| Cash from Financing | 2.16M | 3.02M | 0 | 700K | -31.8K | 1.55M | 681.42K | 3.38M | 4.36M | 5.39M | 1.93M | 3.55M |
| Debt Issued (Net) | 0 | 0 | 0 | 700K | -31.8K | -177.56K | -209.21K | -226.01K | 0 | -153.48K | -226.91K | -223.1K |
| Equity Issued (Net) | 0 | 3.02M | 0 | 0 | 1.73M | 0 | 890.59K | 3.6M | 10.3M | 1.83M | -78.94K | 3.77M |
| Dividends Paid | -83.07K | -90.74K | -163.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.25M | 90.74K | 163.43K | 0 | -1.73M | 1.73M | 36 | 9 | -5.95M | 3.71M | 2.24M | 301 |
| Net Change in Cash | -1.62M | 2.51M | -54.88K | -118.64K | -203.32K | -295.69K | -2.77M | -279.86K | 419.44K | 2.06M | -828.38K | 701.53K |
| Free Cash Flow | -3.97M | -855.69K | -54.88K | -818.63K | -171.52K | -1.85M | -3.45M | -3.75M | -3.94M | -3.33M | -2.76M | -2.85M |
| FCF Margin % | -10961.42% | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -2216.74% | 53.71% | 98.41% | 78.15% | 95.65% | 44.51% | -24.95% | -31.68% | -70343.03% | 21.69% | 39.77% | 64.03% |
| FCF per Share | -2.46 | -0.52 | -0.01 | -0.17 | -0.04 | -0.41 | -1.50 | -2.85 | -11.02 | -8.81 | -24.32 | -24.95 |
| FCF Conversion (FCF/Net Income) | 1.26x | 0.74x | 0.05x | 0.65x | 0.01x | 0.72x | 0.39x | -0.67x | 0.84x | 0.97x | 0.66x | 0.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 5.7K | 8K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |